Thrivent Financial For Lutherans Repligen Corp Transaction History

Thrivent Financial For Lutherans

  • $52.6 Billion
  • Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Repligen Corp stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 638,602 shares of RGEN stock, worth $79.7 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
638,602
Previous 601,829 6.11%
Holding current value
$79.7 Million
Previous $75.9 Million 25.27%
% of portfolio
0.18%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$119.79 - $167.35 $4.41 Million - $6.15 Million
36,773 Added 6.11%
638,602 $95 Million
Q2 2024

Aug 13, 2024
BUY
$120.0 - $182.95 $51 Million - $77.8 Million
425,061 Added 240.46%
601,829 $75.9 Million
Q1 2024

May 14, 2024
SELL
$170.78 - $208.42 $824,525 - $1.01 Million
-4,828 Reduced 2.66%
176,768 $32.5 Million
Q4 2023

Feb 14, 2024
SELL
$114.17 - $185.35 $1.14 Million - $1.85 Million
-9,998 Reduced 5.22%
181,596 $32.7 Million
Q3 2023

Nov 14, 2023
BUY
$138.78 - $176.51 $794,237 - $1.01 Million
5,723 Added 3.08%
191,594 $30.5 Million
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $385,222 - $501,802
2,783 Added 1.52%
185,871 $26.3 Million
Q1 2023

May 17, 2023
BUY
$154.26 - $198.1 $868,483 - $1.12 Million
5,630 Added 3.17%
183,088 $30.8 Million
Q4 2022

Feb 08, 2023
BUY
$162.42 - $220.56 $404,588 - $549,414
2,491 Added 1.42%
177,458 $30 Million
Q3 2022

Nov 14, 2022
SELL
$160.42 - $256.21 $1.47 Million - $2.35 Million
-9,176 Reduced 4.98%
174,967 $32.7 Million
Q2 2022

Aug 16, 2022
SELL
$140.68 - $188.02 $5.8 Million - $7.76 Million
-41,250 Reduced 18.3%
184,143 $29.9 Million
Q1 2022

May 13, 2022
BUY
$161.19 - $257.96 $3.03 Million - $4.86 Million
18,828 Added 9.11%
225,393 $42.4 Million
Q4 2021

Feb 16, 2022
BUY
$247.59 - $304.47 $11 Million - $13.5 Million
44,470 Added 27.43%
206,565 $54.7 Million
Q3 2021

Nov 15, 2021
BUY
$194.77 - $324.21 $9.51 Million - $15.8 Million
48,805 Added 43.08%
162,095 $46.8 Million
Q2 2021

Aug 19, 2021
BUY
$165.87 - $220.95 $268,377 - $357,497
1,618 Added 1.45%
113,290 $22.6 Million
Q1 2021

May 17, 2021
SELL
$180.37 - $226.26 $3.4 Million - $4.26 Million
-18,828 Reduced 14.43%
111,672 $21.7 Million
Q4 2020

Feb 16, 2021
BUY
$148.08 - $206.57 $2.48 Million - $3.46 Million
16,732 Added 14.71%
130,500 $25 Million
Q3 2020

Nov 10, 2020
SELL
$122.51 - $158.27 $331,879 - $428,753
-2,709 Reduced 2.33%
113,768 $16.8 Million
Q2 2020

Aug 12, 2020
SELL
$94.33 - $140.48 $979,900 - $1.46 Million
-10,388 Reduced 8.19%
116,477 $14.4 Million
Q1 2020

May 15, 2020
BUY
$84.96 - $109.14 $25,997 - $33,396
306 Added 0.24%
126,865 $12.2 Million
Q4 2019

Feb 13, 2020
BUY
$73.84 - $93.08 $1.35 Million - $1.7 Million
18,316 Added 16.92%
126,559 $11.7 Million
Q3 2019

Nov 14, 2019
BUY
$76.65 - $95.51 $4.93 Million - $6.14 Million
64,302 Added 146.34%
108,243 $8.3 Million
Q2 2019

Aug 13, 2019
BUY
$54.2 - $85.95 $766,875 - $1.22 Million
14,149 Added 47.49%
43,941 $3.78 Million
Q1 2019

May 14, 2019
BUY
$49.45 - $62.8 $113,784 - $144,502
2,301 Added 8.37%
29,792 $1.76 Million
Q4 2018

Feb 15, 2019
BUY
$48.26 - $68.88 $55,064 - $78,592
1,141 Added 4.33%
27,491 $1.45 Million
Q3 2018

Nov 15, 2018
BUY
$46.8 - $58.97 $26,769 - $33,730
572 Added 2.22%
26,350 $1.46 Million
Q2 2018

Aug 14, 2018
BUY
$35.26 - $47.04 $49,469 - $65,997
1,403 Added 5.76%
25,778 $1.21 Million
Q1 2018

May 08, 2018
BUY
$30.92 - $37.27 $6,585 - $7,938
213 Added 0.88%
24,375 $882,000
Q4 2017

Feb 14, 2018
BUY
$32.53 - $38.92 $42,939 - $51,374
1,320 Added 5.78%
24,162 $877,000
Q3 2017

Nov 14, 2017
BUY
$36.98 - $46.06 $844,697 - $1.05 Million
22,842
22,842 $875,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email